Concert Pharmaceuticals Inc (CNCE.OQ)
CNCE.OQ on NASDAQ Stock Exchange Global Market
13.52USD
21 Sep 2018
13.52USD
21 Sep 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$13.52
$13.52
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
51,996
51,996
52-wk High
$30.70
$30.70
52-wk Low
$12.48
$12.48
About
Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. The Company's deuterated chemical entity platform... (more)
Overall
| Beta: | 0.98 |
| Market Cap(Mil.): | $316.57 |
| Shares Outstanding(Mil.): | 23.42 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CNCE.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 3.07 | 108.33 | 32.69 |
| EPS (TTM): | 4.41 | -- | -- |
| ROI: | 65.77 | 1.50 | 12.72 |
| ROE: | 78.18 | 0.19 | 14.85 |
BRIEF-Concert Pharmaceuticals Reports Q1 Loss Per Share $0.19
* CONCERT PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
BRIEF-Concert Pharmaceuticals Completes Enrollment In Phase 2A Trial Of CTP-543 In Alopecia Areata
* CONCERT PHARMACEUTICALS COMPLETES ENROLLMENT IN PHASE 2A TRIAL OF CTP-543 IN ALOPECIA AREATA
Estimates